30 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.4
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.3
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
zs98mg70n4
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.2
dab r1wcsse0zf
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
l9nrya xdk2mm4pnb9
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
10-K
EX-10.9
3qo8nm7bvslanrb7gwr
29 Mar 22
Annual report
5:09pm
S-1/A
EX-10.5
sdsmynuyh fq9ksfs2d
19 Apr 21
IPO registration (amended)
6:10am
S-1/A
EX-10.1
9i8wx7hb5c yciypoi2l
19 Apr 21
IPO registration (amended)
6:10am
S-1/A
EX-10.6
9p6rdt317wnq48erm2o
19 Apr 21
IPO registration (amended)
6:10am
S-1/A
EX-10.7
6y5ihswdema7n1txvw
19 Apr 21
IPO registration (amended)
6:10am
S-1/A
EX-10.4
lnm2 axfrw7zop0s7a5y
19 Apr 21
IPO registration (amended)
6:10am